Soleno Therapeutics (SLNO) Cash & Equivalents Growth (1y) (2014 - 2026)
Soleno Therapeutics (SLNO) Cash & Equivalents Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 63.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.53% |
| Dec 31, 2025 | -20.27% |
| Sep 30, 2025 | 409.57% |
| Jun 30, 2025 | 34.21% |
| Mar 31, 2025 | 90.03% |
| Dec 31, 2024 | -48.18% |
| Sep 30, 2024 | -7.61% |
| Jun 30, 2024 | 193.81% |
| Mar 31, 2024 | 441.77% |
| Dec 31, 2023 | 1,062.04% |
| Sep 30, 2023 | 165.30% |
| Jun 30, 2023 | -19.50% |
| Mar 31, 2023 | -72.73% |
| Dec 31, 2022 | -31.46% |
| Sep 30, 2022 | -29.92% |
| Jun 30, 2022 | -28.27% |
| Mar 31, 2022 | -30.36% |
| Dec 31, 2021 | -56.72% |
| Sep 30, 2021 | -49.79% |
| Jun 30, 2021 | -46.25% |